Slavin Margaret, Li Huilun, Khatri Manisha, Frankenfeld Cara
Department of Nutrition and Food Studies, George Mason University, Fairfax, VA, USA.
Department of Global and Community Health, George Mason University, Fairfax, VA, USA.
Headache. 2021 Feb;61(2):276-286. doi: 10.1111/head.14065. Epub 2021 Jan 27.
Clinical trials have demonstrated magnesium supplements to be effective for prophylactic treatment of migraine. Dietary magnesium intake of many Americans is known to be below nutritional recommendations, but typical magnesium intake from dietary sources in adults with migraine has not previously been evaluated.
This study aimed to quantify dietary and total (diet + supplement) magnesium consumption of adults with migraine or severe headache in the United States, and to investigate the relationship between magnesium consumption levels and prevalence of migraine or severe headache.
This analysis included cross-sectional data from 3626 participants, 20- to 50-years old in the National Health and Nutrition Examination Survey between 2001 and 2004. Presence of migraine or severe headache in the past 3 months was determined by questionnaire. Individuals responding affirmatively were classified as having migraine, and individuals reporting not experiencing migraine or severe headache were classified as controls. Dietary magnesium intake was determined from a 24-hour recall interview, supplemental magnesium intake was determined from the dietary supplements interview, and total magnesium intake was the sum of dietary and supplement intake.
Mean dietary consumption of magnesium was below the recommended dietary allowance (RDA) for both migraine (n = 905) and control groups (n = 2721). Attainment of the RDA through a combination of diet and supplements was associated with lower adjusted odds of migraine (odds ratio [OR] = 0.83, 95% confidence intervals [CIs] = 0.70, 0.99, p = 0.035). Magnesium consumption in the highest quartile (Q) was associated with lower odds of migraine than in the lowest Q for both dietary (OR = 0.76, 95% CI = 0.63, 0.92, p = 0.006) and total (OR = 0.78, 95% CI = 0.62, 0.99, p = 0.042) magnesium intake in adjusted models.
These results suggest inadequate consumption of magnesium intake is associated with migraine in U.S. adults ages 20-50. Further prospective investigations are warranted to evaluate the role of dietary magnesium intake on migraine.
临床试验表明,补充镁对偏头痛的预防性治疗有效。已知许多美国人的膳食镁摄入量低于营养推荐量,但此前尚未评估偏头痛成年患者从饮食中摄入镁的典型情况。
本研究旨在量化美国偏头痛或严重头痛成年患者的膳食和总(饮食 + 补充剂)镁摄入量,并调查镁摄入量水平与偏头痛或严重头痛患病率之间的关系。
该分析纳入了2001年至2004年美国国家健康与营养检查调查中3626名20至50岁参与者的横断面数据。通过问卷调查确定过去3个月内是否存在偏头痛或严重头痛。回答为肯定的个体被归类为患有偏头痛,报告未经历偏头痛或严重头痛的个体被归类为对照组。通过24小时回忆访谈确定膳食镁摄入量,通过膳食补充剂访谈确定补充镁摄入量,总镁摄入量为膳食和补充剂摄入量之和。
偏头痛组(n = 905)和对照组(n = 2721)的平均膳食镁摄入量均低于推荐膳食摄入量(RDA)。通过饮食和补充剂相结合达到RDA与偏头痛调整后较低的几率相关(优势比[OR] = 0.83,95%置信区间[CI] = 0.70,0.99,p = 0.035)。在调整模型中,膳食(OR = 0.76,95% CI = 0.63,0.92,p = 0.006)和总(OR = 0.78,95% CI = 0.62,0.99,p = 0.042)镁摄入量处于最高四分位数(Q)的人群患偏头痛的几率低于最低Q人群。
这些结果表明,镁摄入量不足与20至50岁美国成年人的偏头痛有关。有必要进行进一步的前瞻性研究,以评估膳食镁摄入量对偏头痛的作用。